Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Open accessAbstract
Breast cancer metastasis involves lymphatic dissemination in addition to hematogenous spreading. Although stromal lymphatic vessels (LVs) serve as initial metastatic routes, roles of organ-residing LVs are underinvestigated. Here we show that lymphatic endothelial cells (LECs), a component of LVs within pre-metastatic niches, are conditioned by triple-negative breast cancer (TNBC) cells to accelerate metastasis. LECs within the lungs and lymph nodes, conditioned by tumour-secreted factors, express CCL5 that is not expressed either in normal LECs or in cancer cells, and direct tumour dissemination into these tissues. Moreover, tumour-conditioned LECs promote angiogenesis in these organs, allowing tumour extravasation and colonization. Mechanistically, tumour cell-secreted IL6 causes Stat3 phosphorylation in LECs. This pStat3 induces HIF-1α and VEGF, and a pStat3-pc-Jun-pATF-2 ternary complex induces CCL5 expression in LECs. This study demonstrates anti-metastatic activities of multiple repurposed drugs, blocking a self-reinforcing paracrine loop between breast cancer cells and LECs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Breast cancer cells condition the premetastatic niche through tumor-lymphatic vessel cross-talk.
“Another mechanism by which breast cancer cells condition the premetastatic niche is through tumor-lymphatic vessel cross-talk.”
From Hypoxic control of metastasis (2016) · cites this paper as [98]
IL-6-induced VEGF expression in LECs is associated with activation of HIF-1.
“Interestingly, IL-6–induced VEGF expression in LECs is associated with the activation of HIF-1”
From Hypoxic control of metastasis (2016) · cites this paper as [98]
Lymphatic vessels at the distant site support metastatic colonization in breast, melanoma, prostate, gastric, and colon cancer patients.
“Lymphatic vessels at the distant site support metastatic colonization in breast, melanoma, prostate, gastric, and colon cancer patients (98).”
From Hypoxic control of metastasis (2016) · cites this paper as [98]
IL-6 secretion by the tumor activates STAT3 signaling in LECs localized within the lymph node and lung to promote CCL5-mediated recruitment of CCR5-positive breast cancer cells into the lymphatic system and VEGF-mediated lung vascular permeability and lymph node angiogenesis.
“IL-6 secretion by the tumor activates signal transducer and activator of transcription 3 (STAT3) signaling in LECs localized within the lymph node and lung to promote (i) CCL5-mediated recruitment of CCR5-positive breast cancer cells into the lymphatic system and (ii) VEGF-mediated lung vascular permeability and lymph node angiogenesis (98).”
From Hypoxic control of metastasis (2016) · cites this paper as [98]
LECs within premetastatic organs are conditioned by tumor-derived factors to facilitate tumor cell recruitment, extravasation, and colonization.
“LECs within premetastatic organs are conditioned by tumor-derived factors to facilitate tumor cell recruitment, extravasation, and colonization (98).”
From Hypoxic control of metastasis (2016) · cites this paper as [98]
Tumor-derived factors may promote lymphatic metastasis at least in part through activation of HIF signaling in LECs.
“indicating that tumor-derived factors may promote lymphatic metastasis at least in part through the activation of HIF signaling in LECs (98).”
From Hypoxic control of metastasis (2016) · cites this paper as [98]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160 · see citing works
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592 · see citing works
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277 · see citing works
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · see citing works
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Valastyan, S., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.09.024 · Cited by 4,011 · see citing works
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288 · see citing works
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
Skobe, M., Hawighorst, T., Jackson, D. G., Prevo, R., Janes, L., Velasco, P., Riccardi, L., Alitalo, K. K., Claffey, K. P., & Detmar, M. J. (2001) · Nature Medicine · doi:10.1038/84643 · Cited by 1,733 · see citing works
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · see citing works
Catlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638 · see citing works
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tammela, T., & Alitalo, K. K. (2010) · Cell · doi:10.1016/j.cell.2010.01.045 · Cited by 1,443 · see citing works
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. C. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2621 · Cited by 1,302 · see citing works
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,187 · see citing works
Stattic: a small-molecule inhibitor of STAT3 activation and dimerization
Schust, J., Sperl, B., Hollis, A., Mayer, T. U., & Berg, T. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.09.018 · Cited by 1,105 · see citing works
The lymphatic vasculature in disease
Alitalo, K. K. (2011) · Nature Medicine · doi:10.1038/nm.2545 · Cited by 964 · see citing works
Siddiquee, K., Zhang, S., Guida, W. C., Blaskovich, M. A., Greedy, B. M., Lawrence, H. R., Yip, M. L. R., Jove, R., McLaughlin, M. M., Lawrence, N. J., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609757104 · Cited by 734 · see citing works
Preparing the “Soil”: The Premetastatic Niche
Kaplan, R. N., Rafii, S., & Lyden, D. C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2407 · Cited by 665 · see citing works
Shields, J. D., Fleury, M. E., Yong, C., Tomei, A. A., Randolph, G. J., & Swartz, M. A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.020 · Cited by 555 · see citing works
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
Wei, L.-H., Kuo, M.-L., Chen, C.-A., Chou, C.-H., Lai, K.-B., Lee, C.-N., & Hsieh, C.-Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206226 · Cited by 536 · see citing works
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Hedvat, M., Huszar, D., Herrmann, A., Gozgit, J. M., Schroeder, A., Sheehy, A. M., Buettner, R., Proia, D. A., Kowolik, C. M., Xin, H., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.10.015 · Cited by 526 · see citing works
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis
Chang, Q., Bournazou, E., Sansone, P., Berishaj, M., Gao, S. P., Daly, L., Wels, J., Theilen, T., Granitto, S., Zhang, X., et al. (2013) · Neoplasia · doi:10.1593/neo.13706 · Cited by 494 · see citing works
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Mantovani, A., Bonecchi, R., & Locati, M. (2006) · Nature Reviews Immunology · doi:10.1038/nri1964 · Cited by 481 · see citing works
Hirakawa, S., Hong, Y., Harvey, N. L., Schacht, V., Matsuda, K. M., Libermann, T. A., & Detmar, M. J. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63851-5 · Cited by 439 · see citing works
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., & Yu, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205859 · Cited by 432 · see citing works
Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04571 · Cited by 427 · see citing works
van Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries‐Smits, L., Herrlich, P., Zantema, A., Angel, P., & van der Eb, A. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05680.x · Cited by 375 · see citing works
Gerhartz, C., Heesel, B., Sasse, J., Hemmann, U., Landgraf, C., Schneider-Mergener, J., Horn, F., Heinrich, P., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12991 · Cited by 351 · see citing works
STAT family of transcription factors in cytokine-mediated biological responses
Takeda, K., & Akira, S. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00005-8 · Cited by 310 · see citing works
Xiong, H., Hong, J., Du, W., Lin, Y., Ren, L., Wang, Y., Su, W., Wang, J., Cui, Y., Wang, Z., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295964 · Cited by 308 · see citing works
CCR7 and CXCR4 as Novel Biomarkers Predicting Axillary Lymph Node Metastasis in T1 Breast Cancer
Cabıoğlu, N., Yazıcı, S., Arun, B., Broglio, K. R., Hortobágyi, G. N., Price, J. E., & Şahin, A. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0014 · Cited by 246 · see citing works
Jenkins, D. E., Hornig, Y. S., Oei, Y. A., Dusich, J., & Purchio, T. F. (2005) · Breast Cancer Research · doi:10.1186/bcr1026 · Cited by 228 · see citing works
Lymphatic endothelium: a new frontier of metastasis research
Karkkainen, M. J., Mäkinen, T., & Alitalo, K. K. (2002) · Nature Cell Biology · doi:10.1038/ncb0102-e2 · Cited by 226 · see citing works
Interacting Regions in Stat3 and c-Jun That Participate in Cooperative Transcriptional Activation
Zhang, X., Wrzeszczynska, M. H., Horvath, C. M., & Darnell, J. E., Jr. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.7138 · Cited by 225 · see citing works
Génin, P., Algarté-Génin, M., Roof, P., Lin, R., & Hiscott, J. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5352 · Cited by 216 · see citing works
Guo, L., Chen, C., Shi, M., Wang, F., Chen, X., Diao, D., Hu, M., Yu, M., Lu, Q., & Guo, N. (2013) · Oncogene · doi:10.1038/onc.2012.573 · Cited by 209 · see citing works
Lehtonen, A., Matikainen, S., Miettinen, M., & Julkunen, I. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.3.511 · Cited by 151 · see citing works
Balanis, N. G., Wendt, M. K., Schiemann, B. J., Wang, Z., Schiemann, W. P., & Carlin, C. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475277 · Cited by 136 · see citing works
Prox1, master regulator of the lymphatic vasculature phenotype
Hong, Y., & Detmar, M. J. (2003) · Cell and Tissue Research · doi:10.1007/s00441-003-0747-8 · Cited by 133 · see citing works
Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
Ara, T., Nakata, R., Sheard, M. A., Shimada, H., Buettner, R., Groshen, S. G., Ji, L., Yu, H., Jove, R., Seeger, R. C., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2353 · Cited by 130 · see citing works
Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas
Liu, F., Cao, J., Wu, J., Sullivan, K., Shen, J. L., Ryu, B., Xu, Z., Wei, W., & Cui, R. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.32 · Cited by 117 · see citing works
Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro
Wick, N., Saharinen, P., Saharinen, J., Gurnhofer, E., Steiner, C. W., Raab, I., Stokic, D., Giovanoli, P., Buchsbaum, S., Burchard, A., et al. (2007) · Physiological Genomics · doi:10.1152/physiolgenomics.00037.2006 · Cited by 106 · see citing works
Casola, A., Garofalo, R. P., Haeberle, H. A., Elliott, T. F., Lin, R., Jamaluddin, M., & Brasier, A. R. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6428-6439.2001 · Cited by 99 · see citing works
Kovacic, J. C., Gupta, R., Lee, A. C., Ma, M., Fang, F., Tolbert, C. N., Walts, A. D., Beltran, L. E., San, H., Chen, G., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40364 · Cited by 95 · see citing works
Basolo, F., Conaldi, P. G., Fiore, L., Calvo, S., & Toniolo, A. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550609 · Cited by 92 · see citing works
STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
Yi, E. H., Lee, C. S., Lee, J., Lee, Y. J., Shin, M. K., Cho, C., Kang, K. W., Lee, S. E., Han, W., Noh, D., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0217 · Cited by 79 · see citing works
Localization of a human T-cell-specific gene, RANTES (D17S136E), to chromosome 17q11.2-q12
Donlon, T. A., Krensky, A. M., Wallace, M. R., Collins, F. S., Lovett, M., & Clayberger, C. (1990) · Genomics · doi:10.1016/0888-7543(90)90485-d · Cited by 78 · see citing works
Reyes‐Gibby, C. C., Spitz, M. R., Wu, X., Merriman, K. W., Etzel, C. J., Bruera, E. D., Kurzrock, R., & Shete, S. S. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0651 · Cited by 68 · see citing works
Endothelial FAK as a therapeutic target in disease
Infusino, G., & Jacobson, J. R. (2011) · Microvascular Research · doi:10.1016/j.mvr.2011.09.011 · Cited by 61 · see citing works
Yeligar, S. M., Machida, K., Tsukamoto, H., & Kalra, V. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901564 · Cited by 58 · see citing works
Role of STAT3 in Transformation and Drug Resistance in CML
Nair, R. R., Tolentino, J. H. G., & Hazlehurst, L. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00030 · Cited by 56 · see citing works
Lee, E., Koskimaki, J. E., Pandey, N. B., & Popel, A. S. (2013) · Neoplasia · doi:10.1593/neo.121638 · Cited by 50 · see citing works
Self-citationCross-Talk between Tumor Cells and the Microenvironment at the Metastatic Niche
Carlini, M. J., Lorenzo, M. S. D., & Puricelli, L. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798377058 · Cited by 38 · see citing works
Lee, E., Pandey, N. B., & Popel, A. S. (2013) · Clinical & Experimental Metastasis · doi:10.1007/s10585-013-9610-9 · Cited by 35 · see citing works
Self-citationIL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130
Taga, T. (1992) · Research in Immunology · doi:10.1016/0923-2494(92)80013-b · Cited by 28 · see citing works
Srebrow, A., Muro, A. F., Werbajh, S., Sharp, P. A., & Kornblihtt, A. R. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81031-t · Cited by 26 · see citing works
Lee, E., Roşca, E., Pandey, N. B., & Popel, A. S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.08.020 · Cited by 23 · see citing works
Self-citationBartsch, R., Woehrer, S., Raderer, M., & Hejna, M. (2006) · PubMed · Cited by 16 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [54]Lee E Pandey NB Popel AS Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model Clin Exp Metastasis 2013 PMC3947147 23963763
Cited by
Sorted by citations
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · see citing works
Characteristics and Significance of the Pre-metastatic Niche
Liu, Y., & Cao, X. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.011 · Cited by 1,287 · see citing works
Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13092053 · Cited by 468 · see citing works
The CCL5/CCR5 Axis in Cancer Progression
Aldinucci, D., Borghese, C., & Casagrande, N. (2020) · Cancers · doi:10.3390/cancers12071765 · Cited by 413 · see citing works
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Qin, J., Li, Y., Zhang, J., & Zhang, W. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1206-z · Cited by 407 · see citing works
Korbecki, J., Grochans, S., Gutowska, I., Barczak, K., & Baranowska‐Bosiacka, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207619 · Cited by 371 · see citing works
Tumor-draining lymph nodes: At the crossroads of metastasis and immunity
du Bois, H., Heim, T. A., & Lund, A. W. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg3551 · Cited by 334 · see citing works
Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
Liu, Q., Zhang, H., Jiang, X., Qian, C., Liu, Z., & Luo, D. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0742-4 · Cited by 328 · see citing works
Hypoxia: Signaling the Metastatic Cascade
Rankin, E. B., Nam, J.-M., & Giaccia, A. J. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.006 · Cited by 240 · see citing works
CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target
Zhang, W., Wang, H., Sun, M., Deng, X., Wu, X., Ma, Y., Li, M., Shuoa, S. M., You, Q., & Miao, L. (2020) · 癌症:英文版 · doi:10.1002/cac2.12010 · Cited by 239 · see citing works
Do, H. T. T., Lee, C. H., & Cho, J. (2020) · Cancers · doi:10.3390/cancers12020287 · Cited by 236 · see citing works
Immune determinants of the pre-metastatic niche
Pătraș, L., Shaashua, L., Matei, I. R., & Lyden, D. C. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.018 · Cited by 223 · see citing works
CD146, from a melanoma cell adhesion molecule to a signaling receptor
Wang, Z., Xu, Q., Zhang, N., Du, X., Xu, G., & Yan, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00259-8 · Cited by 178 · see citing works
Lang, J., Zhao, X., Qi, Y., Zhang, Y., Han, X., Ding, Y., Guan, J., Ji, T., Zhao, Y., & Nie, G. (2019) · ACS Nano · doi:10.1021/acsnano.9b04857 · Cited by 165 · see citing works
Dieterich, L. C., Tacconi, C., Ducoli, L., & Detmar, M. J. (2022) · Physiological Reviews · doi:10.1152/physrev.00039.2021 · Cited by 162 · see citing works
The lymph node pre-metastatic niche
Sleeman, J. P. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1351-6 · Cited by 151 · see citing works
Garg, M., Shanmugam, M. K., Bhardwaj, V., Goel, A., Gupta, R., Sharma, A., Baligar, P., Kumar, A. P., Goh, B. C., Wang, L., et al. (2020) · Medicinal Research Reviews · doi:10.1002/med.21761 · Cited by 142 · see citing works
The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer
Fan, Y., & He, S. (2022) · Cancer Management and Research · doi:10.2147/cmar.s316700 · Cited by 131 · see citing works
Cancer Resistance to Immunotherapy: Comprehensive Insights with Future Perspectives
Said, S. S., & Ibrahim, W. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041143 · Cited by 127 · see citing works
Engineering the pre-metastatic niche
Aguado, B. A., Bushnell, G. G., Rao, S. S., Jeruss, J. S., & Shea, L. D. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0077 · Cited by 125 · see citing works
Kim, J., Lee, C., Kim, I., Ro, J., Kim, J., Min, Y. H., Park, J., Sunkara, V., Park, Y.-S., Michael, I. J., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c04778 · Cited by 120 · see citing works
Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications
Chin, A. R., & Wang, S. E. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0028 · Cited by 114 · see citing works
Tumor metastasis: Mechanistic insights and therapeutic interventions
Liu, M., Yang, J., Xu, B.-S., & Zhang, X. (2021) · MedComm · doi:10.1002/mco2.100 · Cited by 112 · see citing works
Pang, B., Zhao, Y., Luehmann, H. P., Yang, X., Detering, L., You, M., Zhang, C., Zhang, L., Li, Z., Ren, Q., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07968 · Cited by 110 · see citing works
CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells
Zhang, M., Qiu, L., Zhang, Y., Xu, D., Zheng, J., & Li, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-08840-y · Cited by 104 · see citing works
Endothelial cells promote triple‐negative breast cancer cell metastasis via PAI‐1 and CCL5 signaling
Zhang, W., Xu, J., Fang, H., Tang, L., Chen, W., Sun, Q., Zhang, Q., Yang, F., Sun, Z., Cao, L., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700237rr · Cited by 99 · see citing works
Coulson, R. S., Liew, S. H., Connelly, A. A., Yee, N. S., Deb, S., Kumar, B., Vargas, A. C., O'Toole, S. A., Parslow, A. C., Poh, A. R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15553 · Cited by 97 · see citing works
Chemokine Receptor Signaling and the Hallmarks of Cancer
Lacalle, R. A., Blanco, R., Carmona‐Rodríguez, L., Martín‐Leal, A., Mira, E., & Mañes, S. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.09.011 · Cited by 96 · see citing works
Wang, Z., Wang, Z., Li, G., Wu, H., Sun, K., Chen, J., Feng, Y., Chen, C., Cai, S., Xu, J., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.043 · Cited by 95 · see citing works
Jin, K., Pandey, N. B., & Popel, A. S. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0981-3 · Cited by 94 · see citing works
Self-citationShi, H., Zhang, J., Han, X., Li, H., Xie, M., Sun, Y., Liu, W., Ba, X., & Zeng, X. (2016) · International Journal of Cancer · doi:10.1002/ijc.30538 · Cited by 93 · see citing works
In vitro modeling of solid tumor interactions with perfused blood vessels
Kwak, T. J., & Lee, E. (2020) · Scientific Reports · doi:10.1038/s41598-020-77180-1 · Cited by 91 · see citing works
Self-citationThe evolving role of lymphatics in cancer metastasis
Farnsworth, R. H., Achen, M. G., & Stacker, S. A. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.04.008 · Cited by 90 · see citing works
Choi, H., & Moon, A. (2018) · Archives of Pharmacal Research · doi:10.1007/s12272-018-1051-1 · Cited by 90 · see citing works
Breast Cancer Metastasis: Are Cytokines Important Players During Its Development and Progression?
Méndez-García, L. A., Castro, K. E. N., Ochoa-Mercado, T. D. L., Arreola, M. I. P., Ruiz‐Manzano, R. A., Mendoza, M. S., Solleiro-Villavicencio, H., Cázarez-Martínez, C., & Morales‐Montor, J. (2018) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0024 · Cited by 87 · see citing works
Lymphatic Tissue Engineering and Regeneration
Alderfer, L., Wei, A. Y., & Hanjaya‐Putra, D. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0122-7 · Cited by 85 · see citing works
Seo, W., Shimizu, K., Kojo, S., Okeke, A., Kohwi-shigematsu, T., Fujii, S., & Taniuchi, I. (2020) · Nature Communications · doi:10.1038/s41467-020-15375-w · Cited by 81 · see citing works
Chen, X., Feng, L., Huang, Y., Wu, Y., & Xie, N. (2022) · Cancers · doi:10.3390/cancers15010104 · Cited by 81 · see citing works
Obesity: a perfect storm for carcinogenesis
Harris, B. H. L., Macaulay, V. M., Harris, D. A., Klenerman, P., Karpe, F., Lord, S., Harris, A. L., & Buffa, F. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10046-2 · Cited by 80 · see citing works
Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
Pfab, C., Schnobrich, L., Eldnasoury, S., Gessner, A., & El‐Najjar, N. (2021) · Cancers · doi:10.3390/cancers13133193 · Cited by 79 · see citing works
Characteristics of pre-metastatic niche: the landscape of molecular and cellular pathways
Wang, H., Pan, J., Barsky, L., Jacob, J. C., Zheng, Y., Gao, C., Wang, S., Zhu, W., Sun, H., Lu, L., et al. (2021) · Molecular Biomedicine · doi:10.1186/s43556-020-00022-z · Cited by 77 · see citing works
Lee, E., Pandey, N. B., & Popel, A. S. (2015) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2015.2 · Cited by 75 · see citing works
Self-citationCCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer
Pervaiz, A., Zepp, M., Mahmood, S., Ali, D. M., Berger, M. R., & Adwan, H. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0415-3 · Cited by 73 · see citing works
Pro-Inflammatory Cytokines in the Formation of the Pre-Metastatic Niche
Li, R., Wen, A., & Lin, J. (2020) · Cancers · doi:10.3390/cancers12123752 · Cited by 73 · see citing works
Ge, Y., Mu, W., Ba, Q., Li, J., Jiang, Y., Xia, Q., & Wang, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.003 · Cited by 72 · see citing works
The Interplay Between Lymphatic Vessels and Chemokines
Farnsworth, R. H., Karnezis, T., Maciburko, S. J., Mueller, S. N., & Stacker, S. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00518 · Cited by 70 · see citing works
Ayuso, J. M., Gong, M. M., Skala, M. C., Harari, P. M., & Beebe, D. J. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.201900925 · Cited by 70 · see citing works
Carpenter, R., Kwak, J., Peyton, S. R., & Lee, J. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0307-x · Cited by 68 · see citing works
Zhu, X., Shen, H., Yin, X., Long, L., Chen, X., Feng, F., Liu, Y., Zhao, P., Xu, Y., Li, M., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16610 · Cited by 67 · see citing works
Wei, W., Chen, X., Liang, L.-J., Wu, X., Wu, X., Chen-Fei, Z., Wang, Z., Fan, L., Hu, Z., Liang, L., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12837 · Cited by 64 · see citing works
Lugo-Cintrón, K. M., Ayuso, J. M., White, B. R., Harari, P. M., Ponik, S. M., Beebe, D. J., Gong, M. M., & Virumbrales-Muñoz, M. (2020) · Lab on a Chip · doi:10.1039/d0lc00099j · Cited by 64 · see citing works
Li, Y., Li, M., Su, K., Zong, S., Zhang, H., & Xiong, L. (2023) · Theranostics · doi:10.7150/thno.82700 · Cited by 60 · see citing works
Henderson, A. R., Ilan, I. S., & Lee, E. (2021) · Microcirculation · doi:10.1111/micc.12730 · Cited by 56 · see citing works
Self-citationXiao, Y., Hassani, M., Moghaddam, M. B., Fazilat, A., Ojarudi, M., & Valilo, M. (2025) · Medical Oncology · doi:10.1007/s12032-025-02675-8 · Cited by 56 · see citing works
Sun, Z., Wang, C., Lawson, D. A., Kwek, S. S., Velozo, H. G., Owyong, M., Lai, M.-D., Fong, L. H., Wilson, M. W., Su, H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23760 · Cited by 56 · see citing works
Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression
Harris, A. R., Perez, M. J., & Munson, J. M. (2018) · BMC Cancer · doi:10.1186/s12885-018-4619-8 · Cited by 56 · see citing works
Jin, K., Pandey, N. B., & Popel, A. S. (2017) · Oncotarget · doi:10.18632/oncotarget.19417 · Cited by 55 · see citing works
Self-citationZhao, L., Qiu, Z., Yang, Z., Xu, L., Pearce, T. M., Wu, Q., Yang, K., Li, F.-L., Saulnier, O., Fei, F., et al. (2024) · Nature Cancer · doi:10.1038/s43018-023-00658-0 · Cited by 54 · see citing works
Fertig, E. J., Lee, E., Pandey, N. B., & Popel, A. S. (2015) · Scientific Reports · doi:10.1038/srep12133 · Cited by 54 · see citing works
Self-citationKalpana, G., Figy, C., Yeung, M. L., & Yeung, K. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-52746-w · Cited by 53 · see citing works
So, J. Y., Skrypek, N., Yang, H. H., Merchant, A. S., Nelson, G. W., Chen, W.-D. D., Ishii, H., Chen, J. M., Hu, G., Achyut, B. R., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3339 · Cited by 53 · see citing works
Yang, W., Chang, A., Wang, S., Wang, S.-J., Chang, Y.-S., Chang, T.-M., Hsu, S.-K., Fong, Y., & Tang, C. (2016) · Scientific Reports · doi:10.1038/srep28647 · Cited by 52 · see citing works
Xie, L., Qiu, S., Chen, L., Gu, C., Wang, J., Lv, J., Fang, L., Chen, Z., Li, Y., Jiang, T., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02833-8 · Cited by 51 · see citing works
Norton, K., Wallace, T., Pandey, N. B., & Popel, A. S. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0445-x · Cited by 51 · see citing works
Self-citationBiomimetic on-a-chip platforms for studying cancer metastasis
Lee, E., Song, H.-H. G., & Chen, C. S. (2015) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2015.12.001 · Cited by 49 · see citing works
Self-citationInhibition of breast cancer growth and metastasis by a biomimetic peptide
Lee, E., Lee, S. J., Koskimaki, J. E., Han, Z., Pandey, N. B., & Popel, A. S. (2014) · Scientific Reports · doi:10.1038/srep07139 · Cited by 47 · see citing works
Self-citationThe release of tryptase from mast cells promote tumor cell metastasis via exosomes
Xiao, H. F., He, M., Xie, G., Liu, Y., Zhao, Y., Xiong, Y., Li, X., & Zhang, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-6203-2 · Cited by 45 · see citing works
Zhang, W., Yang, S., Chen, D., Yuwen, D., Zhang, J., Wei, X., Han, X., & Guan, X. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04120-1 · Cited by 45 · see citing works
Wang, L.-H., Lin, C., Liu, S.-C., Liu, G., Chen, Y., Chen, J., Chan, C.-H., Lin, T.-Y., Chen, C.-K., Xu, G.-H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9213 · Cited by 44 · see citing works
Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment
Xiao, G., Wang, X., Xu, Z., Liu, Y., & Jing, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02318-6 · Cited by 43 · see citing works
Steinhäuser, S. S., Morera, E., Budková, Z., Schepsky, A., Wang, Q., Rolfsson, Ó., Riedel, A., Krueger, A., Hilmarsdóttir, B., Mælandsmo, G. M., et al. (2020) · Laboratory Investigation · doi:10.1038/s41374-020-0415-6 · Cited by 42 · see citing works
A review concerning the breast cancer-related tumour microenvironment
Rodríguez-Bejarano, O. H., Parra-López, C., & Patarroyo, M. A. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104389 · Cited by 41 · see citing works
Adinew, G. M., Taka, E., Mochona, B., Badisa, R. B., MAZZIO, E. A., Elhag, R. I., & Soliman, K. F. A. (2021) · Nutrients · doi:10.3390/nu14010079 · Cited by 41 · see citing works
Stromal cells in breast cancer as a potential therapeutic target
Dykes, S. S., Hughes, V. S., Wiggins, J. M., Fasanya, H. O., Tanaka, M., & Siemann, D. W. (2018) · Oncotarget · doi:10.18632/oncotarget.25245 · Cited by 39 · see citing works
Ritchie, S., Reed, D. A., Pereira, B., & Timpson, P. (2021) · Faculty Reviews · doi:10.12703/r/10-4 · Cited by 39 · see citing works
Cancer as a homeostatic challenge: the role of the hypothalamus
Francis, N., & Borniger, J. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2021.08.008 · Cited by 39 · see citing works
Stachura, J., Wachowska, M., Kilarski, W. W., Güç, E., Gołąb, J., & Muchowicz, A. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1182278 · Cited by 38 · see citing works
Rapid multilayer microfabrication for modeling organotropic metastasis in breast cancer
Kwak, T. J., & Lee, E. (2020) · Biofabrication · doi:10.1088/1758-5090/abbd28 · Cited by 37 · see citing works
Self-citationMicrofluidic System to Analyze the Effects of Interleukin 6 on Lymphatic Breast Cancer Metastasis
Cho, H., Choi, J., Kim, K.-J., Shin, M., & Choi, J. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.611802 · Cited by 37 · see citing works
CD146 is required for VEGF-C-induced lymphatic sprouting during lymphangiogenesis
Yan, H., Zhang, C., Wang, Z., Tu, T., Duan, H., Luo, Y., Feng, J., Liu, F., & Yan, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-06637-7 · Cited by 37 · see citing works
Henríquez, J. A., Sleeman, J. P., & Garvalov, B. K. (2018) · Clinical & Experimental Metastasis · doi:10.1007/s10585-018-9930-x · Cited by 37 · see citing works
Huang, C., Chang, A., Chen, H., Wang, S., Lo, Y., & Tang, C. (2016) · Clinical Science · doi:10.1042/cs20160117 · Cited by 36 · see citing works
Chen, X., Feng, J., Chen, W., Shao, S., Chen, L., & Wan, H. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00945-w · Cited by 36 · see citing works
Heterogeneity of chemokine cell-surface receptor expression in triple-negative breast cancer.
Norton, K., Popel, A. S., & Pandey, N. B. (2015) · Europe PMC (PubMed Central) · Cited by 35 · see citing works
Self-citationThe biological and clinical significance of stromal-epithelial interactions in breast cancer
McCuaig, R., Wu, F., Dunn, J., Rao, S., & Dahlstrom, J. E. (2016) · Pathology · doi:10.1016/j.pathol.2016.10.009 · Cited by 35 · see citing works
Thorny ground, rocky soil: Tissue-specific mechanisms of tumor dormancy and relapse
Lim, A. R., & Ghajar, C. M. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.007 · Cited by 35 · see citing works
Huang, Y., Miao, Z., Hu, Y., Yuan, Y., Zhou, Y., Wei, L., Zhao, K., Guo, Q., & Lu, N. (2016) · Oncotarget · doi:10.18632/oncotarget.13669 · Cited by 35 · see citing works
Lee, B., Jang, J. Y., Seo, C., & Kim, C. (2020) · The FASEB Journal · doi:10.1096/fj.202001455r · Cited by 34 · see citing works
Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy
Malone, M. K., Smrekar, K., Park, S., Blakely, B., Walter, A. B., Nasta, N., Park, J., Considine, M., Danilova, L., Pandey, N. B., et al. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1739484 · Cited by 33 · see citing works
Self-citationKwon, O. K., Jeon, J. M., Sung, E., Na, A., Kim, S. J., & Lee, S. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20086 · Cited by 32 · see citing works
Furukawa, N., Stearns, V., Santa-Maria, C., & Popel, A. (2022) · Expert opinion on therapeutic targets · doi:10.1080/14728222.2022.2170779 · Cited by 30 · see citing works
Self-citationChen, L., Xu, G., Song, X., Zhang, L., Chen, C., Xiang, G., Wang, S., Zhang, Z., Wu, F., Yang, X., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216635 · Cited by 31 · see citing works
Tumor Microenvironment in Metastatic Colorectal Cancer: The Arbitrator in Patients’ Outcome
Galindo-Pumariño, C., Collado, M., Herrera, M., & Peña, C. (2021) · Cancers · doi:10.3390/cancers13051130 · Cited by 31 · see citing works
The Multifaceted Effects of Breast Cancer on Tumor-Draining Lymph Nodes
Jana, S., Muscarella, R. A., & Jones, D. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.05.006 · Cited by 30 · see citing works
Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach
Rezaeeyan, H., Shirzad, R., McKee, T. D., & Saki, N. (2018) · Apmis · doi:10.1111/apm.12818 · Cited by 29 · see citing works
The Angiogenic Secretome in VEGF overexpressing Breast Cancer Xenografts
Doré-Savard, L., Lee, E., Kakkad, S. M., Popel, A. S., & Bhujwalla, Z. M. (2016) · Scientific Reports · doi:10.1038/srep39460 · Cited by 27 · see citing works
Self-citationHarnessing Biomaterials and the Lymphatic System for ImmunomodulationPreprint
Alderfer, L., Hall, E., & Hanjaya‐Putra, D. (2020) · SSRN Electronic Journal · doi:10.1016/j.actbio.2021.06.006 · Cited by 26 · see citing works
Targeting metastasis with nanomedicine
Pallares, R. M., Consolino, L., Wang, A., Lorenzi, F. D., Kiessling, F. M., Schroeder, A., & Lammers, T. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00358-7 · Cited by 25 · see citing works
Mladinich, M. C., Conde, J. N., Schutt, W. R., Sohn, S., & Mackow, E. R. (2021) · mBio · doi:10.1128/mbio.01962-21 · Cited by 25 · see citing works
Jordan, A. M., Drake, R. J. G., & Hodivala‐Dilke, K. (2025) · Physiological Reviews · doi:10.1152/physrev.00046.2024 · Cited by 24 · see citing works
- Authors
- Lee, E., Fertig, E. J., Jin, K., Sukumar, S., Pandey, N. B., & Popel, A. S.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Popel, Aleksander S.
- Venue
- Nature Communications
- Published
- 2014-09-02
- Volume
- 5
- Issue
- 1
- Pages
- 4715-4715
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4351998
- OpenAlex
- W2001868807
- Cited by
- 197
- References
- 56
- Citations by year
- 2026: 10 · 2025: 18 · 2024: 14 · 2023: 21 · 2022: 22 · 2021: 20 · 2020: 26 · 2019: 10 · 2018: 13 · 2017: 12 · 2016: 19 · 2015: 8 · 2014: 3
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (MDA-MB-231)
- National Cancer Institute (CA141053, K25CA141053, R01CA138264)
- Topics
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Surgery › Lymphatic Disorders and Treatments
- Keywords
- breast cancer metastasis, lymphatic endothelial cells, pre-metastatic niche, triple-negative breast cancer, RANTES, interleukin-6, STAT3 signaling, HIF-1α, vascular endothelial growth factor, angiogenesis, paracrine signaling, drug repurposing, lymphatic dissemination, lung metastasis, lymph node metastasis
- MeSH terms
- Maraviroc, Interleukin-6 Inhibitors, Aminosalicylic Acids, Animals, Benzenesulfonates, Cell Adhesion, Cell Movement, Cyclohexanes, Female, Humans, Lung, Lymph Nodes, Lymphatic Metastasis, Mice, Nude, Neoplasm Transplantation, Transplantation, Heterologous, Triazoles, Interleukin-6, Gene Expression, Culture Media, Conditioned, Chemokine CCL5, Vascular Endothelial Growth Factor A, Lymphatic Vessels, Cell Line, Tumor, Cell Proliferation, STAT3 Transcription Factor, Mice, Hypoxia-Inducible Factor 1, alpha Subunit, Antibodies, Neutralizing, Human Umbilical Vein Endothelial Cells, MCF-7 Cells, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review